HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2022 Issues

Cover

Vol. 24 • No. N1 • February 2022

In this issue:

  • Exploration of the physical health of dual users of heroin and crack in methadone treatment who inject or have previously injected drugs
    Heidebrecht F., Macleod M.B., and Dawkins L.
  • Patterns of new psychoactive substance use among opioid-dependent patients attending for opioid agonist treatment
    McCarron P., Smyth B., Carroll G., Glynn M., Barry J., Whiston L., Keenan E., Darker C., and Truszkowska E.
  • The Role of Familial and Cultural Factors in Relapse of Methadone Maintenance Treated Patients
    Badiei R., Motazedian S., Kheradmand A., and Seif P.
  • Effects of family functions on opioid use disorder patients to remission
    Sahiner I.V., Kir Y., and Sahiner S.
  • Sexual dysfunction in patients with opioid use disorder: a comparison between naltrexone implant and buprenorphine/naloxone maintenance treatment
    Caliskan A.M., and Yildiz M.C.
  • Characteristics of foreign drug addicts assisted by Addiction Centre in Naples, Italy
    Curcio F., Asturaro E., Bandiera F., Barretta V., Fontebasso M., Gautiero G., Rutigliano M.A., Girasole D., Marguccio E., Marsella E., Mazzella C., Nicotra F., Pianese P., Preziuso M., Procida M., Spalice A., Scialò L., and Topa M.

 

Cover

Vol. 24 • No. N2 • April 2022

In this issue:

  • Buprenorphine-Naloxone abuse among Participants in the needle exchange programme. A Finnish Time-Trend Study from 2008 to 2018.
    Fältberg N., Partanen M., Lintonen T., Mishina K., and Niemelä S.
  • Patient Satisfaction with Telemedicine in Addictions
    Mayet S., Arshad S., McCaw I., Hashmani Z., Drozdova Z., Gledhill A., Shahbaz S., and Phillips T.
  • Real-world retention rates with a long-acting buprenorphine depot in opioid-dependent patients attending private clinics in Australia.
    MacDonald T., Connor P., Edwards J., Hardy M., Kemp D., and Johnston L.
  • Relapse rate following institutionalized rehabilitation of male heroin addicts: A Sri Lankan experience
    Darshana N., Wijesinghe C., and De Silva V.
  • Prevalence of Suboptimal Dosing of Methadone and Buprenorphine and Associated Factors in Opioid Dependent Patients
    Al-Dewaissan F.B.A.A., Hill D.R., Evans L., and Luz T.C.B.
  • Exploring impaired insight in opioid addiction: the role of self-stigma
    Eidenmueller K., Grimm F., Hermann D., Frischknecht U., Kiefer F., Dziobek I., and Bekier N.K.

 

Cover

Vol. 24 • No. N3 • June 2022

In this issue:

  • Trends in Cigarette Smoking among Italian Substance Use Disorder Patients
    Miccoli M., Poli A., Maremmani A.G.I., Della Rocca F., Pani P.P., and Maremmani I.
  • Results of a survey among opioid addiction treatment providers on the importance of physical exercise
    Spitzer U., Meyer M., Guggisberg E., Mirek K., Walter M., and Dursteler K.M.
  • Baclofen in the Treatment of Alcohol Withdrawal Syndrome in Opioid-Dependent Patients
    Gibbons Z., McCarron P., Santlal K., McCarthy R., and Keenan E.
  • Improving Attendance in Addictions. Do Quality Improvement Plans Work?
    Mayet S., Shahbaz S., and Arshad S.
  • Opium use and risk of stroke: a systematic review and meta-analysis
    Borhani-Haghighi A., Tabrizi R., Estakhr M., Hosseini-Bensenjan M., Niknam M., Iravani Saadi M., Moazzen F., and Nowrouzi-Sohrabi P.
  • Challenges and solutions for opioid dependence therapy during the SARS-CoV-2 pandemic in Germany
    Poehlke T.
  • P300 Event-Related Potentials as a Marker of Craving in Opioid Use Disorder: a Systematic Literature Review
    Skrenes A., Labonté L.E., Muñoz-Violant S., Khehra J., Krigolson O., and Schütz C.

 

Cover

Vol. 24 • No. N4 • August 2022

In this issue:

  • Pilot study using long acting injectable buprenorphine (LAIB) as a novel treatment option in NHS Lanarkshire Addiction Services in Scotland
    Stewart E., Marr E., and Hill D.
  • How to Assess Visibility of Drug-Related Stigmatized Behaviours? Does the Choice of Method Matter?
    Rastegari A., Haghdoost A., Mehrolhassani M.H., Azizian M., HajiMaghsoudim S., and Baneshi M.R.
  • Nutritional status of patients in methadone, buprenorphine, and opium tincture maintenance therapy
    Kheradmand A., Samani N., and Fazeli A.
  • Prescription opioids use and opioid-related mortality monitoring in Slovenia
    Kostnapfel T., Jandl M., Hočevar Grom A., Korošec A., and Kastelic A.
  • Quality of life differential changes from psychopathological episodes through recovery in Heroin Addiction
    Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page